source
- Ionis secures FDA approval for Zanvastro, first disease-modifying therapy for rare Alexander diseaseIonis Pharmaceuticals announced that the U.S. Food and Drug Administration has approved Zanvastro, marking the first disease-modifying treatment for Alexander disease, a rare and often fatal neurol…
- B. Braun recalls three lots of 0.9% Sodium Chloride injection due to zinc oxide particlesB. Braun Medical Inc announced a voluntary recall of three lots of its 0.9% Sodium Chloride Injection USP, 100 mL, packaged in a 150 mL PAB® container. The recall was triggered after testing ident…